4.93
price down icon1.20%   -0.06
after-market Dopo l'orario di chiusura: 4.95 0.02 +0.41%
loading
Precedente Chiudi:
$4.99
Aprire:
$4.62
Volume 24 ore:
23,473
Relative Volume:
0.01
Capitalizzazione di mercato:
$7.36M
Reddito:
$8.62M
Utile/perdita netta:
$-6.15M
Rapporto P/E:
-0.447
EPS:
-11.03
Flusso di cassa netto:
$-5.32M
1 W Prestazione:
-13.51%
1M Prestazione:
-17.97%
6M Prestazione:
-8.70%
1 anno Prestazione:
-14.11%
Intervallo 1D:
Value
$4.61
$5.08
Intervallo di 1 settimana:
Value
$4.61
$5.6999
Portata 52W:
Value
$1.94
$12.32

Evoke Pharma Inc Stock (EVOK) Company Profile

Name
Nome
Evoke Pharma Inc
Name
Telefono
858-345-1494
Name
Indirizzo
420 STEVENS AVENUE, SOLANA BEACH, CA
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
EVOK's Discussions on Twitter

Confronta EVOK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
EVOK
Evoke Pharma Inc
4.93 8.17M 8.62M -6.15M -5.32M -11.03
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.44 66.04B 9.39B 2.61B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.77 45.57B 29.98B 958.27M 5.31B 0.2964
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.69 42.50B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.21 18.84B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
309.72 13.59B 2.99B 1.21B 1.13B 25.06

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-06-22 Aggiornamento H.C. Wainwright Neutral → Buy
2019-03-05 Downgrade H.C. Wainwright Buy → Neutral
2018-03-08 Reiterato B. Riley FBR, Inc. Buy
2017-10-19 Ripresa FBR & Co. Buy
2017-03-16 Reiterato Rodman & Renshaw Buy
2017-01-30 Aggiornamento Laidlaw Neutral → Buy
2017-01-05 Aggiornamento Rodman & Renshaw Neutral → Buy
2016-12-23 Reiterato Rodman & Renshaw Neutral
2016-07-19 Reiterato FBR Capital Outperform
2016-07-19 Downgrade Noble Financial Buy → Hold
2016-07-18 Downgrade Rodman & Renshaw Buy → Neutral
2016-03-16 Iniziato Northland Capital Outperform
2016-03-14 Reiterato Ascendiant Capital Markets Buy
2016-02-17 Ripresa FBR Capital Outperform
2014-12-03 Reiterato MLV & Co Buy
2014-11-07 Iniziato MLV & Co Buy
2014-04-22 Iniziato Laidlaw Buy
2013-11-19 Iniziato Aegis Capital Buy
Mostra tutto

Evoke Pharma Inc Borsa (EVOK) Ultime notizie

pulisher
09:34 AM

What machine learning models say about Evoke Pharma Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser

09:34 AM
pulisher
09:20 AM

Will Volume Confirm Reversal in Evoke Pharma Inc.July 2025 Market Mood & Fast Gain Stock Trading Tips - 선데이타임즈

09:20 AM
pulisher
09:10 AM

Using data filters to optimize entry into Evoke Pharma Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser

09:10 AM
pulisher
07:09 AM

Evoke Pharma Inc. stock trendline breakdown2025 Volatility Report & Smart Money Movement Alerts - Newser

07:09 AM
pulisher
01:57 AM

Why Evoke Pharma Inc. stock attracts strong analyst attentionWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser

01:57 AM
pulisher
12:03 PM

Is Evoke Pharma Inc. trending in predictive chart modelsConsistent Profit Signals with AI Models - Newser

12:03 PM
pulisher
Aug 12, 2025

Using RSI to spot recovery in Evoke Pharma Inc.Consistent Return Setup with Exit Strategy - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How sentiment analysis helps forecast Evoke Pharma Inc.Buy Strategy Review With Performance Summary - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Can a trend reversal in Evoke Pharma Inc. lead to recoveryFree Real Market Momentum Signal Generator - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Tools to monitor Evoke Pharma Inc. recovery probabilityIntelligent Trade Forecast With AI Analytics - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Published on: 2025-08-11 01:03:10 - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Earnings Based Stock Performance Forecast - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Top Risks to Consider Before Buying Evoke Pharma Inc. StockBond Market & Weekly Chart Analysis and Trade Guides - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com

Aug 09, 2025
pulisher
Aug 08, 2025

Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Evoke Pharma Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 07, 2025

Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038 - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma extends GIMOTI patent protection until 2038 - Investing.com

Aug 06, 2025
pulisher
Aug 06, 2025

Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru

Aug 04, 2025
pulisher
Aug 03, 2025

How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News

Aug 03, 2025

Evoke Pharma Inc Azioni (EVOK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.63
price up icon 4.37%
$17.81
price up icon 2.18%
drug_manufacturers_specialty_generic RDY
$14.26
price up icon 2.52%
$10.41
price up icon 2.87%
$131.62
price up icon 2.12%
$309.72
price up icon 2.76%
Capitalizzazione:     |  Volume (24 ore):